文献速递其他结缔组织病

系统性硬化症肺动脉高压筛查的循证策略

An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis.
PubMed 文献 · Semin Arthritis Rheum · 2020-03-02

该病例对照研究纳入925例系统性硬化症患者,构建多变量逻辑回归模型预测肺动脉高压概率,确定1.1%为100%敏感性的截断值,低于该值的患者占46.2%且无一例发生肺动脉高压,提示近半数患者可能无需每年筛查超声心动图。

要点

  • 气短、DLCO和NT-proBNP是肺动脉高压的独立预测因子
  • 预测概率低于1.1%的患者中无肺动脉高压发生,占研究人群46.2%
  • 简单预测模型可识别极低概率患者,可能免于年度筛查超声心动图

核心结论

  • 简单预测模型可识别肺动脉高压极低概率的系统性硬化症患者,这些患者可能免于年度筛查超声心动图,约占一般人群近一半。

研究设计与样本

  • 多中心纵向队列巢式病例对照研究,纳入925例未选择的系统性硬化症受试者,采用多变量逻辑回归模型计算肺动脉高压概率。

主要发现

  • 气短、DLCO和NT-proBNP为肺动脉高压的独立预测因子。
  • 所有系统性硬化症相关肺动脉高压病例的预测概率均>1.1%,低于该截断值的受试者占46.2%且无肺动脉高压发生。

关键数值与推荐

  • 预测概率截断值定为1.1%,在此阈值下敏感性为100%,低于该值的受试者无肺动脉高压发生。
  • 研究人群 predominantly 女性(87.5%),平均(SD)年龄58.6(11.7)岁,病程18.2(12.2)年。

临床怎么用

  • 预测模型评分系统可在http://pahtool.ladydavis.ca免费获取,可用于识别可能免于年度超声心动图筛查的极低概率患者。
  • 该策略为未选择系统性硬化症队列中合理使用随访超声心动图的首个循证研究,但尚需验证。

局限性

  • 研究为病例对照设计,需外部验证后方可推广。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical practice guidelines recommend screening all systemic sclerosis (SSc) patients for pulmonary arterial hypertension (PAH) with yearly echocardiograms. There is a paucity of evidence to support these guidelines. RESEARCH QUESTION: Can a prediction model identify SSc patients with a very low probability of PAH and therefore not requiring annual screening echocardiogram? STUDY DESIGN AND METHODS: We performed a case-control study of 925 unselected SSc subjects nested in a multi-centered, longitudinal cohort. The probability of PAH for each subject was calculated using the results of multivariate logistic regression models. A cut-off was identified for the estimated probability of PAH below which no subject developed PAH (100% sensitivity). RESULTS: Study subjects were predominantly female (87.5%), with mean (SD) age 58.6 (11.7) years and disease duration of 18.2 (12.2) years. Thirty-seven subjects developed PAH during 5407.97 person-years of observation (incidence rate 0.68 per 100 person-years). Shortness of breath (SOB), diffusing capacity for carbon monoxide (DLCO) and NT-proBNP were independent predictors of PAH. All SSc-PAH cases had a probability of PAH of >1.1%. Subjects below this cut-off, none of whom had PAH, accounted for 46.2% of the study population. INTERPRETATION: A simple prediction model identified subjects at very low probability of PAH who could potentially forego annual screening echocardiogram. This represents almost half of SSc subjects in a general SSc population. This study, which is the first evidence-based study for the rational use of follow-up echocardiograms in an unselected SSc cohort, requires validation. The scoring system is freely available online at http://pahtool.ladydavis.ca.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Semalulu T, Rudski L, Huynh T, et al. An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis. Semin Arthritis Rheum. 2020. PMID: 32245697. doi:10.1016/j.semarthrit.2020.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。